Why Novavax Shares Vaulted Higher Today
It's a little complicated.
What's Behind Alexion's Impressive Q3 Results
The biotech delivered strong top- and bottom-line growth and boosted its full-year outlook.
Why Investors Loved Moderna's Q3 Results
The biotech has plenty of cash and could be on the verge of its biggest success ever.
Why Penumbra Stock Is Popping Today
The healthcare company posted better-than-expected Q3 results.
Why BioNTech Stock Is Jumping Today
The overall stock market surge appears to be inspiring investors to leap back into the German biotech stock.
Why the Luster of Gilead's Strong Q3 Results Isn't as Bright as It Seems
Sales soared for the biotech's new COVID-19 drug, but Gilead faces some challenges in other areas.
Here's the Clear Leader in Developing a Coronavirus Vaccine for Kids
So far, only one late-stage study evaluating a COVID-19 vaccine candidate includes children.
These 3 Stocks Are Buys No Matter What Happens in the 2020 Election
Here are three top stocks that offer win-win propositions.
Thank Otezla for Amgen's Q3 Revenue and Earnings Beats
Without the purchase of the blockbuster autoimmune disease drug, Amgen's latest results wouldn't have looked nearly as good.
Why Coronavirus Vaccine Stocks Moderna, Novavax, and Inovio Are Sinking Today
The overall stock market sell-off is pulling all three biotech stocks down.
AstraZeneca and J&J Resume Late-Stage Trials: How It Shakes Up the Coronavirus Vaccine Race
Some things have changed, but others haven't.
How DexCom Trounced Wall Street Estimates in Q3
The diabetes care technology provider also again raised its full-year guidance.
Why Kala Pharmaceuticals Stock Sank Today
Good news from the FDA translated to bad news for Kala's share price.
How Pfizer Missed an Opportunity With Its Q3 Results
The big drugmaker posted mixed third-quarter numbers. However, several key catalysts should be right around the corner.
Why Novavax Stock Is Moving Higher Today
The biotech gave an encouraging update about its late-stage coronavirus vaccine program.
5 Top Stocks for November
These stocks should provide you with plenty to be thankful for over the long run.
Why Scholar Rock Stock Is Skyrocketing Today
Investors are fired up about the company's interim phase 2 results for an experimental spinal muscular atrophy drug.
Could Some Coronavirus Vaccines Be Left Out in the Cold?
Some coronavirus vaccines must be stored at extremely low temperatures. Could this limit their market potential?
Market Crash 2.0: Where to Invest $1,000
These three stocks should win if another market crash is at hand. And they should perform well if the bull market continues, too.
3 Stocks You Can Still Buy on Sale in a Ridiculously Expensive Market
And they all offer attractive dividends, too.